Bright Minds Biosciences's total assets for Q3 2025 were C$52.50M, a decrease of -7.03% from the previous quarter. TSE:DRUG total liabilities were C$667.83K for the fiscal quarter, a -8.11% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.